Isotechnika Pharma Inc IPHAF

RE: Another financing?

[DaveAu]

It would seem to make a lot more sense to cut a Psoriasis deal with an upfront payment than to dilute now, assuming there are interested partners. If a financing is in the works now, they'll likely push it below a dollar first so they can get a 25% discount. So we may see 40 million bucks raised at .70 with a half warrant attached. That would require 57 million shares and 28 million warrants. They would pay 6% commission plus costs and that would give them less than 1 more year of cash. Another possibility is that they just hang on until the 2B results are known in the spring. At that point, the price may recover or they may be able to arrange a short term loan to get them thru the Roche deadline.